These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1425833)

  • 21. Intratumoral heterogeneity in DNA ploidy of bladder carcinomas.
    Sasaki K; Hamano K; Kinjo M; Hara S
    Oncology; 1992; 49(3):219-22. PubMed ID: 1495749
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical significance of flow cytometric deoxyribonucleic acid measurements of deparaffinized specimens in bladder tumors.
    Miao T; Wang Z; Sang N; Xiong R; Cao S
    Eur Urol; 1992; 21(2):98-102. PubMed ID: 1499623
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DNA-Flow cytometric analysis of bladder TCC using paraffin-embedded tissues.
    Wu L; Lochhead A; Yang J; Ow KT; Russell PJ
    Urol Int; 1998 Aug; 60(4):208-15. PubMed ID: 9701732
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biological behaviour and DNA cytophotometry of urothelial bladder carcinoma.
    Hofstaedter F; Jakse G; Lederer B; Mikuz G; Delgado R
    Br J Urol; 1984 Jun; 56(3):289-95. PubMed ID: 6544613
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Image cytometry determination of ploidy level, proliferative activity, and nuclear size in a series of 314 transitional bladder cell carcinomas.
    van Velthoven R; Petein M; Oosterlinck WJ; Zandona C; Zlotta A; Van der Meijden AP; Pasteels JL; Roels H; Schulman C; Kiss R
    Hum Pathol; 1995 Jan; 26(1):3-11. PubMed ID: 7821913
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DNA flow cytometry and 67Ki proliferating index as prognostic factors of early recurrence and progression in G1-G2/Ta-T1 and G3/Ta-T1 transitional cell carcinoma of the bladder.
    Tizzani A; Casetta G; Gontero P; Giammò A; Ghabin H; Demurtas S; Pacchioni D
    Minerva Urol Nefrol; 1997 Sep; 49(3):141-3. PubMed ID: 9396221
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Retrospective study of prognostic importance of DNA flow cytometry of urinary bladder carcinoma.
    Blomjous CE; Schipper NW; Baak JP; van Galen EM; de Voogt HJ; Meyer CJ
    J Clin Pathol; 1988 Jan; 41(1):21-5. PubMed ID: 3343376
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DNA ploidy of bladder cancer using bladder biopsy supernate specimens.
    Loughman NT; Lin BP; Dent OF; Newland RC
    Anal Quant Cytol Histol; 2003 Jun; 25(3):146-58. PubMed ID: 12882086
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DNA cytometric features in biopsies of TaT1 urothelial cell cancer predict recurrence and stage progression more accurately than stage, grade, or treatment modality.
    Baak JP; Bol MG; van Diermen B; Janssen EA; Buhr-Wildhagen SB; Mestad O; Øgreid P; Kjellevold KH
    Urology; 2003 Jun; 61(6):1266-72. PubMed ID: 12809927
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Image cytometric DNA analysis in transitional cell carcinoma of the bladder.
    Schapers RF; Ploem-Zaaijer JJ; Pauwels RP; Smeets AW; van den Brandt PA; Tanke HJ; Bosman FT
    Cancer; 1993 Jul; 72(1):182-9. PubMed ID: 8508404
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Significance and application of DNA ploidy of bladder cancer cells in studying the malignancy of tumors].
    Cao S
    Zhonghua Yi Xue Za Zhi; 1990 Mar; 70(3):143-5. PubMed ID: 2163740
    [No Abstract]   [Full Text] [Related]  

  • 32. Flow cytometric DNA ploidy analysis in canine transitional cell carcinoma of urinary bladders.
    Clemo FA; DeNicola DB; Carlton WW; Morrison WB; Walker E
    Vet Pathol; 1994 Mar; 31(2):207-15. PubMed ID: 8203084
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ABH isoantigens in bladder carcinoma patients grouped according to DNA changes over time.
    Borgström E; Gustafson H
    Scand J Urol Nephrol; 1987; 21(2):125-30. PubMed ID: 3616504
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Prognostic significance of DNA content in transitional cell carcinoma of the urinary bladder].
    Sun X
    Zhonghua Zhong Liu Za Zhi; 1992 Jan; 14(1):24-6. PubMed ID: 1396041
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fluorescence in situ hybridization identifies more aggressive types of primarily noninvasive (stage pTa) bladder cancer.
    Pycha A; Mian C; Haitel A; Hofbauer J; Wiener H; Marberger M
    J Urol; 1997 Jun; 157(6):2116-9. PubMed ID: 9146595
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The prognostic significance of deoxyribonucleic acid flow cytometry in muscle invasive bladder carcinoma treated with preoperative irradiation and cystectomy.
    Jacobsen AB; Pettersen EO; Amellem O; Berner A; Ous S; Fosså SD
    J Urol; 1992 Jan; 147(1):34-7. PubMed ID: 1729547
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytomorphometric and flow cytometric analysis of bladder transitional cell carcinoma using acridine orange fluorochrome: correlation with histopathology and clinical behavior.
    Yu DS; Hsu CM; Chang SY; Ma CP
    J Formos Med Assoc; 1992 Feb; 91(2):152-8. PubMed ID: 1364210
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytofluorimetric evaluation of DNA ploidy in the diagnosis of bladder cancer.
    Armone S; Voce S; dal Pozzo C; Severini G; Montanari F; Monti G; Tavolazzi L
    Arch Esp Urol; 1998 Jun; 51(5):507-10. PubMed ID: 9675952
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cellular DNA content and proliferative activity evaluated by flow cytometry versus histopathological and staging classifications in human bladder tumors.
    de Vita R; Forte D; Maggi F; Eleuteri P; Di Silverio F
    Eur Urol; 1991; 19(1):65-73. PubMed ID: 2007422
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical evaluation of cell deoxyribonucleic acid content measured by flow cytometry in bladder cancer.
    Bittard H; Lamy B; Billery C
    J Urol; 1996 Jun; 155(6):1887-91. PubMed ID: 8618280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.